VREX: Varex Imaging Corporation EV/EBITDA Multiple

Corporate emblem and logo of Varex Imaging Corporation (VREX)

Demand for highly skilled engineers underscores the technological complexity of Varex Imaging products. The EV/EBITDA valuation multiple for heavy business reflects current market dynamics, where 10.82 shows the current value of the metric. The company's strategy relies on logistics optimization, stable management, and growing market share in detectors, which directly depends on the capital expenditures of the largest medtech manufacturers.

Varex Imaging Corp. - VREX Enterprise Value to EBITDA Ratio (period 11/23/2025 - 11/11/2026)

Summary analytical data breakdowns for vareximaging.com (VREX)

- stock price and consensus target price:
Stock Quotes Varex|VREX - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Varex Imaging Corp.|VREX - Company Buyout Price
- issuer book value statistics:
Book Value per Share Varex Imaging|VREX - Company Net Assets|Market Cap to Net Assets Ratio vareximaging.com|VREX - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity Varex Imaging|VREX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Varex Imaging Corporation|VREX - Company Cumulative Debt|Debts to Book Capitalization Varex Imaging Corp.|VREX - Company Long-Term Indebtedness|Company Short-Term Debts Varex Imaging|Quick Ratio vareximaging.com
- financial results and valuation multiples details:
VREX - Net Income|Projected Future Earnings Varex Imaging|VREX - P/E Multiple|Future Price to Earnings Varex Imaging|VREX - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Varex Imaging Corp.|VREX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Varex Imaging|VREX - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months vareximaging.com|VREX - Net earnings per share change in current year|Expected earnings per share growth for next year Varex Imaging
Initial company analysis:Varex VREX
Original product of vareximaging.com

This ratio compares the total enterprise value to its operating profit before depreciation and interest, determining the company's ability to service debt during revenue declines. By analyzing the EV/EBITDA chart against historical data, an investor can assess how the aggressive pressure from behemoth customers on Varex Imaging (VREX) margins affects the fair value of assets amid prolonged product certification cycles.

Competitor analysis for Varex Imaging

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|GE HealthCare - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio mt.com MTD|WAT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bio-Techne Corp|Enterprise Value to EBITDA Ratio BRKR|AZTA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Semler Scientific, Inc. (SMLR)|Enterprise Value to EBITDA Ratio butterflynetwork.com BFLY|EV/EBITDA Multiple MLAB (Mesa Labs)|Quantum-Si Inc. (QSI) - Company Value to EBITDA|Nanox - EV/EBITDA Multiple|QTRX (Quanterix Inc) - Enterprise Value to Operating Income Before Depreciation|MASS: EV/EBITDA Multiple|CV - Total Company Value to Operating Income Before Depreciation Ratio|MXCT (MaxCyte) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Rapid Micro (RPID)|EV/EBITDA Multiple SEER|EV/EBITDA Multiple Hyperfine Medical (HYPR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FONAR Corporation FONR|Daxor Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya Biosciences, Inc. (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)